TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited May 28, 1976
TCL Archive In Brief: Friedman Leads FDA During Search; Mead Retires From NCI; Freireich Honored March 14, 1997